Business Development focus in rapid growth Cannabis Category
Filed with ASX · · 3 pages · English
Nexalis Therapeutics Limited on 6ix
Story so far
Earlier from Nexalis Therapeutics
- Amended - Appendix 4C September 2018 Quarter
- Commercial Sales and Distribution Agreement with CBDS Health
- First production completed for strong vape segment growth
- LSH Acquires Seng Vital for Cannabis Opportunities
- Lifespot Strengthens Go-To-Market Cannabis Strategy
Later from Nexalis Therapeutics
- Lifespot signs Heads of agreement with IONIC brands
- Production of new slim line Smart Vaporiser for usa
- Private Placement Successfully Completed to raise $330,000
- Pause in trading
- Response to ASX Price Query
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics